Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Periphe...
Saved in:
| Published in | PLOS ONE Vol. 12; no. 3; p. e0174103 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science (PLoS)
22.03.2017
Public Library of Science |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0174103 |
Cover
| Abstract | Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A.
Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry.
CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets.
The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. |
|---|---|
| AbstractList | Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-[gamma] production in NK cells were evaluated using RT-PCR and flow cytometry. CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-[gamma] production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46.sup.high NKG2A.sup.high subset). The frequencies of NKp46.sup.high NKG2A.sup.high subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46.sup.high NKG2A.sup.high subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-[gamma] expression was lower in the NKp46.sup.high NKG2A.sup.high subset than in the other subsets. The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46.sup.high NKG2A.sup.high subset, may be associated with liver injury and HBV replication. Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A.BACKGROUND AND AIMNatural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A.Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry.PATIENTS/METHODPeripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry.CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets.RESULTSCHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets.The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication.CONCLUSIONThe NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Patients/Method Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry. Results CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets. Conclusion The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Patients/Method Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-[gamma] production in NK cells were evaluated using RT-PCR and flow cytometry. Results CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-[gamma] production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46.sup.high NKG2A.sup.high subset). The frequencies of NKp46.sup.high NKG2A.sup.high subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46.sup.high NKG2A.sup.high subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-[gamma] expression was lower in the NKp46.sup.high NKG2A.sup.high subset than in the other subsets. Conclusion The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46.sup.high NKG2A.sup.high subset, may be associated with liver injury and HBV replication. BACKGROUND AND AIM:Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. PATIENTS/METHOD:Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry. RESULTS:CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets. CONCLUSION:The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-γ production in NK cells were evaluated using RT-PCR and flow cytometry. CHB patients were classified into treatment-naïve patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-γ production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naïve CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-γ expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets. The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This study investigated the frequencies and roles of NK cells in CHB, with a focus on activating receptor NKp46 and inhibitory receptor NKG2A. Patients/Method Peripheral blood lymphocytes were obtained from 71 CHB patients and 37 healthy subjects (HS). The expressions of NKp46 and NKG2A were analyzed using flow cytometry. The role of NKp46-ligand was assessed using an in vitro co-culture system. Cytotoxicity and IFN-[gamma] production in NK cells were evaluated using RT-PCR and flow cytometry. Results CHB patients were classified into treatment-naive patients with low HBV DNA titer (CHB-L; n = 28), high HBV DNA titer (CHB-H; n = 24) by the cut-off level of serum HBV DNA 4 log copies/ml, and patients receiving nucleos(t)ide analogue (CHB-NA; n = 19). The expressions of NKp46 and NKG2A were higher in CHB-H than in HS/CHB-L/CHB-NA. HepG2.2.15 had higher NKp46-ligand expression than HepG2. When NK cells from HS were co-cultured with HepG2.2.15, inhibition of the NKp46 and NKp46-ligand interaction by anti-NKp46 antibody significantly reduced cytolysis of HepG2.2.15 and IFN-[gamma] production. However, those reductions were not observed in co-culture with HepG2. Additionally, NK cells that highly expressed NKp46 also highly expressed NKG2A (NKp46highNKG2Ahigh subset). The frequencies of NKp46highNKG2Ahigh subset in CHB-H were higher than those in HS/CHB-L/CHB-NA. Among treatment-naive CHB patients, the frequencies of NKp46highNKG2Ahigh subset were positively correlated with serum ALT (P<0.01, r = 0.45) and HBV DNA (P<0.01, r = 0.59) levels. The expressions of Fas-L, STAT1, TRAIL and CD107a were higher and IFN-[gamma] expression was lower in the NKp46highNKG2Ahigh subset than in the other subsets. Conclusion The NKp46 and NKp46-ligand interaction contributes to NK cell activation. A novel NK cell subset, the NKp46highNKG2Ahigh subset, may be associated with liver injury and HBV replication. |
| Audience | Academic |
| Author | Kumiko Nishio Yoshinobu Yokoyama Teppei Yoshioka Takahiro Suda Hayato Hikita Ryotaro Sakamori Tetsuo Takehara Tadashi Kegasawa Takuya Miyagi Tomohide Tatsumi Akira Nishio Minoru Shigekawa Kaori Mukai |
| AuthorAffiliation | Academia Sinica, TAIWAN Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan |
| AuthorAffiliation_xml | – name: Academia Sinica, TAIWAN – name: Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan |
| Author_xml | – sequence: 1 givenname: Teppei orcidid: 0000-0002-3608-0554 surname: Yoshioka fullname: Yoshioka, Teppei – sequence: 2 givenname: Tomohide surname: Tatsumi fullname: Tatsumi, Tomohide – sequence: 3 givenname: Takuya surname: Miyagi fullname: Miyagi, Takuya – sequence: 4 givenname: Kaori surname: Mukai fullname: Mukai, Kaori – sequence: 5 givenname: Kumiko surname: Nishio fullname: Nishio, Kumiko – sequence: 6 givenname: Akira surname: Nishio fullname: Nishio, Akira – sequence: 7 givenname: Yoshinobu surname: Yokoyama fullname: Yokoyama, Yoshinobu – sequence: 8 givenname: Takahiro surname: Suda fullname: Suda, Takahiro – sequence: 9 givenname: Tadashi surname: Kegasawa fullname: Kegasawa, Tadashi – sequence: 10 givenname: Minoru surname: Shigekawa fullname: Shigekawa, Minoru – sequence: 11 givenname: Hayato surname: Hikita fullname: Hikita, Hayato – sequence: 12 givenname: Ryotaro surname: Sakamori fullname: Sakamori, Ryotaro – sequence: 13 givenname: Tetsuo surname: Takehara fullname: Takehara, Tetsuo |
| BackLink | https://cir.nii.ac.jp/crid/1870302167727027968$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/28328926$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1tr2zAYhs3oWLuu_2Bsho6xXSTT-bCLQdatXWhpYadbIVtyouJYmWSX9d9PbtwSl8KKQRafn_eV_H7S82yn8Y3NspcQTCHm8MOl70Kj6-k6lacAcgIBfpLtQYnRhCGAd7bmu9lBjK4AhGLIAQXPsl0kMBISsb3sy3GwfzrblNe5bkwefG1zX-Xnp2vCbirnpydolrsmX9q1bl3rYv45v3Khi6lY2bJ1vnmRPa10He3B8N7Pfh1__Xn0bXJ2cTI_mp1NSoFAO5FaC4MEAAWwRDPBJUUF4FxUvKKFgNoIbgkShJGKCmQoYwgWGFaAWlxQivez1xvfde2jGjKICiYnyQgDOBHzDWG8vlTr4FY6XCuvnbop-LBQOrSurK0yWFICja60sURaIbU12lRpSoXG2iavT8NqXbGyprRNG3Q9Mh1_adxSLfyVojjFLmUyeDcYBJ8yjq1auVjautaN9V2_byEklxzTx6CAcMQwS-jhPfThIAZqodO_pk75tMWyN1UzIlKwUvB-2ekDVHqMXbkyna3KpfpI8H4kSExr_7YL3cWo5j--P569-D1m326xS6vrdhl93fWnK47BV9tNuevG7YlOANkAZfAxBlvdIRCo_u7cxqX6u6OGu5NkH-_JStfqfvmUiKv_J36zETfOJV0_plYADBBknCMOEJdM4H-HByXa |
| CitedBy_id | crossref_primary_10_1007_s10238_019_00564_9 crossref_primary_10_1002_JLB_2A1118_421R crossref_primary_10_1007_s12016_024_09010_5 crossref_primary_10_3748_wjg_v25_i16_1950 crossref_primary_10_1016_j_celrep_2018_03_023 crossref_primary_10_1016_j_jhep_2019_03_012 crossref_primary_10_1155_2021_2178143 crossref_primary_10_3390_ijms20205080 crossref_primary_10_3390_cancers11101469 crossref_primary_10_1002_rmv_2007 crossref_primary_10_1016_j_imbio_2022_152272 crossref_primary_10_3389_fimmu_2023_1079495 crossref_primary_10_3389_fimmu_2017_01176 |
| Cites_doi | 10.1016/j.jhep.2012.09.029 10.1073/pnas.95.9.5199 10.1016/j.jhep.2006.05.013 10.1371/journal.pone.0135874 10.1002/hep.24556 10.1128/JVI.02289-09 10.1002/hep.25771 10.1016/j.it.2005.02.007 10.1038/35059110 10.1002/hep.25804 10.1053/j.gastro.2009.08.066 10.1016/j.it.2013.01.003 10.1073/pnas.1118834109 10.1053/j.gastro.2009.05.047 10.1084/jem.187.5.813 10.1016/j.jhep.2010.07.009 10.3748/wjg.v17.i9.1152 10.1073/pnas.84.2.444 10.1016/j.jhep.2010.03.018 10.1182/blood-2003-05-1716 10.1016/j.smim.2006.03.003 10.1084/jem.186.7.1129 10.1016/j.jhep.2009.05.030 10.1084/jem.188.5.953 10.1053/j.gastro.2012.10.039 10.1038/icb.2013.98 10.1084/jem.20121172 10.1182/blood-2007-09-077438 10.4049/jimmunol.173.10.6072 10.1111/hepr.12619 10.3389/fimmu.2012.00351 10.1371/journal.pone.0086927 10.1146/annurev.immunol.19.1.197 10.1002/hep.23977 10.1371/journal.pone.0049135 10.1126/science.1198687 10.1016/S1471-4906(01)02060-9 10.1038/nature10624 10.1016/j.it.2007.04.001 10.1073/pnas.84.4.1005 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 Public Library of Science 2017 Yoshioka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Yoshioka et al 2017 Yoshioka et al |
| Copyright_xml | – notice: COPYRIGHT 2017 Public Library of Science – notice: 2017 Yoshioka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Yoshioka et al 2017 Yoshioka et al |
| DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0174103 |
| DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection (subscription) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database (ProQuest) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database (subscription) Nursing & Allied Health Premium Advanced Technologies & Aerospace Database (ProQuest) ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database (ProQuest) Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: DOA name: Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Sciences (General) |
| DocumentTitleAlternate | NKp46 and NKG2A in HBV infection |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1879964603 oai_doaj_org_article_d39541dafade49e89aedadf49e58a3ae PMC5362099 4321089741 A486629875 28328926 10_1371_journal_pone_0174103 |
| Genre | Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RYH RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX CITATION 3V. CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c820t-9aa8d2800b0e4a687952b0778f7f5b81ad87e428464f582d56621b31f05e3b553 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun May 07 16:28:43 EDT 2023 Wed Aug 27 01:30:39 EDT 2025 Thu Aug 21 17:52:43 EDT 2025 Mon Sep 08 07:18:09 EDT 2025 Mon Sep 08 07:16:49 EDT 2025 Fri Jul 25 10:25:16 EDT 2025 Tue Jun 17 21:10:22 EDT 2025 Tue Jun 10 20:27:42 EDT 2025 Fri Jun 27 05:00:20 EDT 2025 Fri Jun 27 05:10:18 EDT 2025 Thu May 22 21:13:43 EDT 2025 Wed Feb 19 02:32:30 EST 2025 Tue Jul 01 01:43:34 EDT 2025 Thu Apr 24 22:54:16 EDT 2025 Thu Jun 26 22:13:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c820t-9aa8d2800b0e4a687952b0778f7f5b81ad87e428464f582d56621b31f05e3b553 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceptualization: T. Tatsumi TM.Data curation: TY KM.Formal analysis: TY KM.Funding acquisition: T. Takehara.Investigation: YY TS TK.Methodology: KM AN KN.Project administration: T. Tatsumi TM.Resources: RS MS HH.Supervision: T. Takehara.Validation: TY T. Tatsumi.Visualization: TY T. Tatsumi.Writing – original draft: TY T. Tatsumi.Writing – review & editing: TY T. Tatsumi TM KM KN AN YY TS TK MS HH RS T. Takehara. |
| ORCID | 0000-0002-1580-607X 0000-0003-2488-7315 0000-0002-3608-0554 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0174103 |
| PMID | 28328926 |
| PQID | 1879964603 |
| PQPubID | 1436336 |
| PageCount | e0174103 |
| ParticipantIDs | plos_journals_1879964603 doaj_primary_oai_doaj_org_article_d39541dafade49e89aedadf49e58a3ae pubmedcentral_primary_oai_pubmedcentral_nih_gov_5362099 proquest_miscellaneous_1888979735 proquest_miscellaneous_1880472636 proquest_journals_1879964603 gale_infotracmisc_A486629875 gale_infotracacademiconefile_A486629875 gale_incontextgauss_ISR_A486629875 gale_incontextgauss_IOV_A486629875 gale_healthsolutions_A486629875 pubmed_primary_28328926 crossref_primary_10_1371_journal_pone_0174103 crossref_citationtrail_10_1371_journal_pone_0174103 nii_cinii_1870302167727027968 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-03-22 |
| PublicationDateYYYYMMDD | 2017-03-22 |
| PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-22 day: 22 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLOS ONE |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2017 |
| Publisher | Public Library of Science (PLoS) Public Library of Science |
| Publisher_xml | – name: Public Library of Science (PLoS) – name: Public Library of Science |
| References | PA Lang (ref33) 2012; 109 M Jinushi (ref22) 2004; 173 C Bottino (ref38) 2005; 26 ref2 N Lee (ref34) 1998; 95 W Li (ref12) 2015; 10 MA Caligiuri (ref29) 2008; 112 Z Zhang (ref41) 2011; 53 T Tsurimoto (ref27) 1987; 84 SH Lee (ref6) 2007; 28 F Borrego (ref21) 1998; 187 R Zhao (ref26) 2011; 17 SN Waggoner (ref32) 2012; 481 L Golden-Mason (ref23) 2011; 54 H Achdout (ref35) 2010; 84 JF Perz (ref1) 2006; 45 T Tatsumi (ref8) 2016; 46 J Zhao (ref10) 2012; 7 L Golden-Mason (ref37) 2012; 56 T Miyagi (ref40) 2010; 53 E Vivier (ref3) 2011; 331 A Moretta (ref18) 2001; 19 G Ahlenstiel (ref39) 2010; 138 MA Sells (ref25) 1987; 84 S Sivori (ref17) 1997; 186 DH Raulet (ref5) 2006; 18 TI Arnon (ref20) 2004; 103 J Koch (ref16) 2013; 34 B Oliviero (ref9) 2009; 137 P Bonorino (ref13) 2009; 51 Y Li (ref14) 2014; 9 MA Cooper (ref28) 2001; 22 MU Mondelli (ref31) 2012; 3 PH Kruse (ref36) 2014; 92 B Krämer (ref30) 2012; 56 L Micco (ref11) 2013; 58 ET Tjwa (ref42) 2011; 54 A Pessino (ref15) 1998; 188 A Nishio (ref4) 2016 O Mandelboim (ref19) 2001; 409 F Li (ref24) 2013; 144 D Peppa (ref7) 2013; 210 |
| References_xml | – volume: 58 start-page: 225 issue: 2 year: 2013 ident: ref11 article-title: Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B publication-title: J Hepatol doi: 10.1016/j.jhep.2012.09.029 – volume: 95 start-page: 5199 issue: 9 year: 1998 ident: ref34 article-title: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.9.5199 – volume: 45 start-page: 529 issue: 4 year: 2006 ident: ref1 article-title: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide publication-title: J Hepatol doi: 10.1016/j.jhep.2006.05.013 – year: 2016 ident: ref4 article-title: CD14(+) monocyte-derived Galectin-9 induces NK cell cytotoxicity in chronic hepatitis C publication-title: Hepatology – volume: 10 start-page: e0135874 issue: 8 year: 2015 ident: ref12 article-title: Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation publication-title: PLoS One doi: 10.1371/journal.pone.0135874 – volume: 54 start-page: 1559 issue: 5 year: 2011 ident: ref23 article-title: Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C publication-title: Hepatology doi: 10.1002/hep.24556 – volume: 84 start-page: 3993 issue: 8 year: 2010 ident: ref35 article-title: Killing of avian and Swine influenza virus by natural killer cells publication-title: J Virol doi: 10.1128/JVI.02289-09 – volume: 56 start-page: 1214 issue: 4 year: 2012 ident: ref37 article-title: Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity publication-title: Hepatology doi: 10.1002/hep.25771 – volume: 26 start-page: 221 issue: 4 year: 2005 ident: ref38 article-title: Cellular ligands of activating NK receptors publication-title: Trends Immunol doi: 10.1016/j.it.2005.02.007 – volume: 409 start-page: 1055 issue: 6823 year: 2001 ident: ref19 article-title: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells publication-title: Nature doi: 10.1038/35059110 – volume: 56 start-page: 1201 issue: 4 year: 2012 ident: ref30 article-title: Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis publication-title: Hepatology doi: 10.1002/hep.25804 – volume: 138 start-page: 325 issue: 1 year: 2010 ident: ref39 article-title: Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.08.066 – volume: 34 start-page: 182 issue: 4 year: 2013 ident: ref16 article-title: Activating natural cytotoxicity receptors of natural killer cells in cancer and infection publication-title: Trends Immunol doi: 10.1016/j.it.2013.01.003 – volume: 109 start-page: 1210 issue: 4 year: 2012 ident: ref33 article-title: Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1118834109 – volume: 137 start-page: 1151 issue: 3 year: 2009 ident: ref9 article-title: Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.05.047 – volume: 187 start-page: 813 issue: 5 year: 1998 ident: ref21 article-title: Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis publication-title: J Exp Med doi: 10.1084/jem.187.5.813 – volume: 54 start-page: 209 issue: 2 year: 2011 ident: ref42 article-title: Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B publication-title: J Hepatol doi: 10.1016/j.jhep.2010.07.009 – volume: 17 start-page: 1152 issue: 9 year: 2011 ident: ref26 article-title: Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2 publication-title: World J Gastroenterol doi: 10.3748/wjg.v17.i9.1152 – ident: ref2 – volume: 84 start-page: 444 issue: 2 year: 1987 ident: ref27 article-title: Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.84.2.444 – volume: 53 start-page: 424 issue: 3 year: 2010 ident: ref40 article-title: Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection publication-title: J Hepatol doi: 10.1016/j.jhep.2010.03.018 – volume: 103 start-page: 664 issue: 2 year: 2004 ident: ref20 article-title: The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 publication-title: Blood doi: 10.1182/blood-2003-05-1716 – volume: 18 start-page: 145 issue: 3 year: 2006 ident: ref5 article-title: Missing self recognition and self tolerance of natural killer (NK) cells publication-title: Semin Immunol doi: 10.1016/j.smim.2006.03.003 – volume: 186 start-page: 1129 issue: 7 year: 1997 ident: ref17 article-title: p46, a novel natural killer cell-specific surface molecule that mediates cell activation publication-title: J Exp Med doi: 10.1084/jem.186.7.1129 – volume: 51 start-page: 458 issue: 3 year: 2009 ident: ref13 article-title: Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C publication-title: J Hepatol doi: 10.1016/j.jhep.2009.05.030 – volume: 188 start-page: 953 issue: 5 year: 1998 ident: ref15 article-title: Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity publication-title: J Exp Med doi: 10.1084/jem.188.5.953 – volume: 144 start-page: 392 issue: 2 year: 2013 ident: ref24 article-title: Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.10.039 – volume: 92 start-page: 221 issue: 3 year: 2014 ident: ref36 article-title: Natural cytotoxicity receptors and their ligands publication-title: Immunol Cell Biol doi: 10.1038/icb.2013.98 – volume: 210 start-page: 99 issue: 1 year: 2013 ident: ref7 article-title: Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion publication-title: J Exp Med doi: 10.1084/jem.20121172 – volume: 112 start-page: 461 issue: 3 year: 2008 ident: ref29 article-title: Human natural killer cells publication-title: Blood doi: 10.1182/blood-2007-09-077438 – volume: 173 start-page: 6072 issue: 10 year: 2004 ident: ref22 article-title: Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection publication-title: J Immunol doi: 10.4049/jimmunol.173.10.6072 – volume: 46 start-page: 416 issue: 5 year: 2016 ident: ref8 article-title: Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma publication-title: Hepatol Res doi: 10.1111/hepr.12619 – volume: 3 start-page: 351 year: 2012 ident: ref31 article-title: Natural killer cell functional dichotomy: a feature of chronic viral hepatitis? publication-title: Front Immunol doi: 10.3389/fimmu.2012.00351 – volume: 9 start-page: e86927 issue: 2 year: 2014 ident: ref14 article-title: Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B publication-title: PLoS One doi: 10.1371/journal.pone.0086927 – volume: 19 start-page: 197 year: 2001 ident: ref18 article-title: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.19.1.197 – volume: 53 start-page: 73 issue: 1 year: 2011 ident: ref41 article-title: Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients publication-title: Hepatology doi: 10.1002/hep.23977 – volume: 7 start-page: e49135 issue: 11 year: 2012 ident: ref10 article-title: Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients publication-title: PLoS One doi: 10.1371/journal.pone.0049135 – volume: 331 start-page: 44 issue: 6013 year: 2011 ident: ref3 article-title: Innate or adaptive immunity? The example of natural killer cells publication-title: Science doi: 10.1126/science.1198687 – volume: 22 start-page: 633 issue: 11 year: 2001 ident: ref28 article-title: The biology of human natural killer-cell subsets publication-title: Trends Immunol doi: 10.1016/S1471-4906(01)02060-9 – volume: 481 start-page: 394 issue: 7381 year: 2012 ident: ref32 article-title: Natural killer cells act as rheostats modulating antiviral T cells publication-title: Nature doi: 10.1038/nature10624 – volume: 28 start-page: 252 issue: 6 year: 2007 ident: ref6 article-title: Keeping NK cells in highly regulated antiviral warfare publication-title: Trends Immunol doi: 10.1016/j.it.2007.04.001 – volume: 84 start-page: 1005 issue: 4 year: 1987 ident: ref25 article-title: Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.84.4.1005 |
| SSID | ssib045317050 ssib045318062 ssib045324867 ssib045316197 ssib045319074 ssib045319085 ssib045319086 ssib045316121 ssib045318733 ssib045316049 ssib045317797 ssib045315901 ssib045318737 ssib045317988 ssj0053866 |
| Score | 2.293626 |
| Snippet | Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains unclear. This... Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains... BACKGROUND AND AIM:Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains... Background and Aim Natural Killer (NK) cells are involved in the control of viral infection. However, the role of NK cells in chronic hepatitis B (CHB) remains... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref nii |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e0174103 |
| SubjectTerms | Adult Aged Aged, 80 and over Analysis Biology and life sciences Cell activation Cell culture Cell Line, Tumor Chronic infection Coculture Techniques Coculture Techniques - methods Cytolysis Cytometry Cytotoxicity Deoxyribonucleic acid Development and progression DNA DNA, Viral DNA, Viral - genetics Female Flow cytometry Gastroenterology Genetic aspects Health aspects Hep G2 Cells Hepatitis Hepatitis B Hepatitis B virus Hepatitis B virus - genetics Hepatitis B, Chronic Hepatitis B, Chronic - metabolism Hepatology Humans Infections Interferon Interferon-gamma Interferon-gamma - metabolism Killer cells Killer Cells, Natural Killer Cells, Natural - metabolism Ligands Liver Lymphocyte Activation Lymphocyte Activation - physiology Lymphocytes Male Medicine Medicine and health sciences Middle Aged Natural Cytotoxicity Triggering Receptor 1 Natural Cytotoxicity Triggering Receptor 1 - metabolism Natural killer cells NK Cell Lectin-Like Receptor Subfamily C NK Cell Lectin-Like Receptor Subfamily C - metabolism NKG2 antigen Pathogenesis Patients Peripheral blood Physiological aspects Polymerase chain reaction Q R Research and Analysis Methods Research Article Science Stat1 protein T cell receptors Toxicity TRAIL protein Trends University graduates Viral infections Virus Replication Virus Replication - genetics Viruses γ-Interferon |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BT1wQ5dVACgtCAg5u7X3vMQVCoSJIQFFv1tprU0uVE8UJEv-eGXtt1aiiHLhYkfdbOZ7H7kwy-w0hL3Jppc8MjxTPRSQyz6IMotpI8zz3uS6Edfh7x6eFOj4VH8_k2aVWX1gT1tEDd4I79NxKkXhXOg8TC2Nd4Z0v4aM0jrsCV9_Yxn0y1a3B4MVKhYNyXCeHQS8Hq2VdHIANiqRvkhU2opavf1iVb9ZVhWSnF8vmqsDzz_rJSxvS_A65HSJJOuveYJfcKOq7ZDf4akNfBULp1_fI2_m6K5j-RV3tKRYU0mVJFycrodo7i5P3bEarmp4XWGC9qRp6RH9W621D-2Kt-j45nb_79uY4Ct0Tohx29U1knTOeQTyYxYVwCpuKsyzW2pS6lJlJnDegCtidlCilYR7iOpZkPCljWfBMSv6A7NQgrz1ChYCZ3jOvci3iTFkty8RYI1zhIGJiE8J7UaZ5oBbHDhcXaft_mYYUo5NJigpIgwImJBpmrTpqjWvwR6ilAYvE2O0NMJc0mEt6nblMyFPUcdqdMh3cO50JsBhmIXubkOctAskxaqy--eG2TZN--Pz9H0Bfv4xALwOoXII4chdOPMA7IenWCDkdIcHF89HwPlgkiBavicFFmiUK8iIdM22VmZA9tNVeag1iII8VCoU27e336uFnwzA-FCvu6mK5RYxBIlHF1V8xxmqrOXzDh51LDNrBFljGMpitR84yUt94pK7OW35zCUEVJC6P_oe-H5NbDAOxmEeMTcnOZr0t9iGM3GRP2hXjN8-gbac priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZokRAXRMujCy0YhAQc0ia248cJbYFtoWqRgKLeIidO2khVsmx2kfj3zCROIKgqXFZRPN4k8_LYHn9DyIssNrFLNQ8kz0QgUseCFKLaQPEsc5nKhbG43nF8Ig9Pxcez-MwvuDU-rbL3ia2jdnWGa-R7WBXbSCFD_mb-PcCqUbi76ktorJGbEYw0qOd6dtB7YrBlKf1xOa6iPS-d3Xld5bugiSLqS2X54ahF7R9881pVlgh5elk3V4Wff2dR_jEsze6SOz6epNNOATbIjbzaJLeO_Y75JtnwxtvQVx5h-vU98m626DKof1JbOYoZhrQu6MnRXMj2zsnRAZvSsqIXOWZcL8uG7tMf5WLV0D57q7pPTmfvv749DHw5hSCDYX4ZGGu1YxAgpmEurMQq4ywNldKFKuJUR9ZpkA0MV1IUsWYOAj0WpTwqwjjnaRzzB2S9AtZtESoE9HSOOZkpEabSqLiItNHC5hZCKDYhvOdqknmscSx5cZm0G2gK5hwdexKUReJlMSHB0GveYW38g34fBTbQIlJ2e6NenCfe8BLHTSwiZwvrQPFybWzurCvgMtaW23xCnqK4k-7Y6WDvyVSA8jAD07kJed5SIFpGhek453bVNMmHT9_-g-jL5xHRS09U1MCOzPojEPBNiMI1otweUYLNZ6PmHVBOYC3-gmWAp2aRhImSCpkyUk_IFqptz7Um-W098M-9Kl_d_GxoxodiCl6V1yuk0YgsKrm8lkYbZRSHN3zYWccgHayJpQ2D3mpkNyPxjVuq8qIFPI8hyoKZzKPrX_0xuc0w5gp5wNg2WV8uVvkORIzL9EnrFn4BvAhl_g priority: 102 providerName: ProQuest |
| Title | Frequency and role of NKp46 and NKG2A in hepatitis B virus infection |
| URI | https://cir.nii.ac.jp/crid/1870302167727027968 https://www.ncbi.nlm.nih.gov/pubmed/28328926 https://www.proquest.com/docview/1879964603 https://www.proquest.com/docview/1880472636 https://www.proquest.com/docview/1888979735 https://pubmed.ncbi.nlm.nih.gov/PMC5362099 https://doaj.org/article/d39541dafade49e89aedadf49e58a3ae http://dx.doi.org/10.1371/journal.pone.0174103 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2ceGCWF4b6BaDkIBDqsZxbOeAULu0u7DaghaKeoucONmtVCWlaRF74bczk5c2qDzExYriGaWdhz2TjL8h5Hnk-Z4JlWsLN-I2Dw2zQ4hqbelGkYlkzH2N7zvOJ-J0yt_PvNkOqXu2VgLMt6Z22E9qulr0vn-9fgMO_7ro2iCdmqm3zNK4BxbGHYT_3Ie9SWA6ds6b7wrg3UJUB-h-x4nwwGDmyke8hRt7VQHp3yzcu-l8jnioiyzfFpv-WmJ5Y88a3yG3q2CTDkrrOCA7cXqXHFTunNOXFeb0q3vk7XhV1lRfU50aijWHNEvo5GzJRXFncnbCBnSe0qsYa7DX85wO6bf5apPTup4rvU-m49Hn41O7arBgR7Dxr21fa2UYhIxhP-ZaYN9xFvalVIlMvFA52ijQFmxggieeYgZCP-aErpP0vdgNPc99QPZSEN0hoZwDpzHMiEjyfih86SWO8hXXsYagilnErUUZRBX6ODbBWATFJzUJWUgpkwB1EVS6sIjdcC1L9I2_0A9RSw0tYmcXN7LVZVC5YmBc3-OO0Yk2YIqx8nVstEng0lPa1bFFnqCOg_IgarMCBAMOxsN8SPAs8qygQPyMFAt0LvUmz4N3H778A9GnixbRi4ooyUAcka4ORcB_QlyuFmWnRQmrQNSaPgKLBNHi6ChcxxmYv8TjhtIXyiKHaKu11HKkgVSXCxRap7bf7dNPm2l8KBblpXG2QRqFWKPCFX-kUb70pQu_8GHpEo12ajeziGw5S0t97Zl0flVAoHsQd0Fu8-i_OR-TWwwDtL5rM9Yhe-vVJj6C8HIddsmunEkY1bGD4_ikS_aHo8nHi27xwqZbrCg4_hj9BObgfDk |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BpDAl4QGx8rbMwgEPCQLXEcfzwg1DFGR7ciwYb6Fpw42SpNSWla0P4Uv5G7fEHQNHjZS1XF58a977PPd4Q8iwMd2Ej5jvBj7vDIMicCr9aRfhzbWCZcG9zvOByJwTH_MA7GS-RncxcG0yobnVgqapvHuEe-jV2xteDC9d9MvznYNQpPV5sWGhVbDJPzHxCyFa_3d4G-zxnbe3f0duDUXQWcGKzd3NHGKMvAT4rchBuBzbZZ5EqpUpkGkfKMVbBE0NqCp4FiFvwd5kW-l7pB4kcBdokAlX-d4844yI8ctwEe6A4h6ut5vvS2a27YmuZZsgWcz72mNVdt_souAa0tuJZNJlhi9SwvLnJ3_87a_MMM7t0ht2v_lfYrhlshS0m2Sm4c1if0q2SlVhYFfVlXtH51l-zuzaqM7XNqMksxo5HmKR0Np1yUT0bD96xPJxk9TTDDez4p6A79PpktCtpki2X3yPGVIPo-Wc4AdWuEcg4zrWVWxJK7kdAySD2lFTeJAZeN9YjfYDWM69rm2GLjLCwP7CTEOBV6QqRFWNOiR5x21rSq7fEP-B0kWAuLlbnLB_nsJKwFPbS-DrhnTWosMHqitEmssSl8DZTxTdIjm0jusLrm2uqXsM-BeZiG8LFHnpYQWJ0jw_SfE7MoinD_45f_APr8qQP0ogZKc0BHbOorF_CfsOpXB3K9Awk6Ju4MbwBzAmrxEyQRLAPzBARm0mVSC9Uja8i2DdaK8Le0wi83rHzx8JN2GF-KKX9Zki8QRmElU-GLS2GUllr6sMIHlXS01MEeXEozmC07ctMhX3ckm5yWBdYD8Oogcnp4-dI3yc3B0eFBeLA_Gj4itxj6e67vMLZOluezRbIB3uo8elyqCEq-XrVO-gUD96DZ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEC2PBlpqEAg4uLXX630cEEoJoSU0IEpRb2bttdtIlR3iBNS_xq9jxl4bjKrCpZco8s7Gzjy-nfHOzhDyJAlVaGIZuDxImMtiQ90YvFpXBEliEpEypfF9x8GY7x2xd8fh8RL52ZyFwbTKBhMroDZFgu_Id7ArtuKMe8FOZtMiPg6Gr6bfXOwghTutTTuNWkVG6fkPCN_Kl_sDkPVTSodvPr_ec22HATeBlW_uKq2loeAzxV7KNMfG2zT2hJCZyMJY-tpIeFxAcM6yUFIDvg_148DPvDAN4hA7RgD8XxcBeFVgS-K4DfYARzi3R_UC4e9YzdieFnm6DVbA_KZNl10Kq44B7bpwLZ9MsNzqWVFe5Pr-ncH5x5I4vEVuWl_W6dfKt0qW0nyNrBzY3fo1smqBo3Se2-rWL26TwXBWZ2-fOzo3DmY3OkXmjEdTxqsr49Fb2ncmuXOaYrb3fFI6u873yWxROk3mWH6HHF0Jo--S5RxYt04cxmCmMdTwRDAv5kqEmS-VZDrV4L7RHgkarkaJrXOO7TbOomrzTkC8U7MnQllEVhY94razpnWdj3_Q76LAWlqs0l1dKGYnkTX6yAQqZL7RmTag9KlUOjXaZPA1lDrQaY9sobij-shrizVRn4HyUAWhZI88riiwUkeOOn-iF2UZ7X_48h9Eh586RM8sUVYAOxJtj1_Af8IKYB3KjQ4l4E3SGd4E5QTW4idYJawS1OcQpAmPCsVlj6yj2jZcK6Pflgu_3KjyxcOP2mG8Kab_5WmxQBqJVU15wC-lkUoosMUeuVdbRysd7MclFYXZomM3HfF1R_LJaVVsPQQPD6Ko-5c_-hZZATSK3u-PRw_IDYqunxe4lG6Q5flskW6C4zqPH1YI4ZCvVw1JvwAquKUY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+and+role+of+NKp46+and+NKG2A+in+hepatitis+B+virus+infection&rft.jtitle=PloS+one&rft.au=Yoshioka%2C+Teppei&rft.au=Tatsumi%2C+Tomohide&rft.au=Miyagi%2C+Takuya&rft.au=Mukai%2C+Kaori&rft.date=2017-03-22&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=12&rft.issue=3&rft_id=info:doi/10.1371%2Fjournal.pone.0174103&rft_id=info%3Apmid%2F28328926&rft.externalDocID=PMC5362099 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |